FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to novel and useful pharmaceutical compositions containing a cyclodextrin compound and a budesonide derivative, for treating and/or preventing neutrophil inflammation in a patient suffering inflammatory pulmonary disease. Budesonide derivative forms a complex with a cyclodextrin compound in stoichiometric ratio of 1:1.
EFFECT: said complex is used in the IL17 level reduction method, in the CXCL-1 level reduction method in a patient suffering inflammatory pulmonary disease.
42 cl, 23 dwg, 1 tbl, 11 ex
Authors
Dates
2020-05-29—Published
2015-03-30—Filed